Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   phenylketonuria
  

Disease ID 84
Disease phenylketonuria
Definition
A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).
Synonym
phenylalaninemia
phenylketonuria (disorder)
phenylketonuria (pku)
phenylketonuria - pku
phenylketonuria [pku]
phenylketonurias
phenylketonurias [disease/finding]
phenylketouria
pku
pku phenylketonuria
Orphanet
OMIM
DOID
UMLS
C0031485
MeSH
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:13)
C0025362  |  mental retardation  |  3
C0023418  |  leukemia  |  1
C0011849  |  diabetes mellitus  |  1
C0027765  |  neurological disorder  |  1
C0027765  |  neurological disorders  |  1
C0011847  |  diabetes  |  1
C0023467  |  acute myeloblastic leukemia  |  1
C0042075  |  urological disorders  |  1
C0158699  |  renal agenesis  |  1
C0031485  |  phenylalaninemia  |  1
C0948265  |  metabolic syndrome  |  1
C1263846  |  attention deficit hyperactivity disorder  |  1
C0030486  |  paraplegia  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:4)
QDPR  |  5860  |  CTD_human;UniProtKB-KW
GCH1  |  2643  |  UniProtKB-KW
PAH  |  5053  |  CLINVAR;CTD_human;UniProtKB-KW;GHR
PTS  |  5805  |  UniProtKB-KW
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:1)
5053  |  PAH  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:172)
1080  |  CFTR  |  DISEASES
1595  |  CYP51A1  |  DISEASES
8935  |  SKAP2  |  DISEASES
64132  |  XYLT2  |  DISEASES
5009  |  OTC  |  DISEASES
4826  |  NNAT  |  DISEASES
5010  |  CLDN11  |  DISEASES
55808  |  ST6GALNAC1  |  DISEASES
8508  |  NIPSNAP1  |  DISEASES
158  |  ADSL  |  DISEASES
2954  |  GSTZ1  |  DISEASES
10278  |  EFS  |  DISEASES
79152  |  FA2H  |  DISEASES
1666  |  DECR1  |  DISEASES
2765  |  GML  |  DISEASES
2936  |  GSR  |  DISEASES
2639  |  GCDH  |  DISEASES
56521  |  DNAJC12  |  DISEASES
2584  |  GALK1  |  DISEASES
3945  |  LDHB  |  DISEASES
338  |  APOB  |  DISEASES
33  |  ACADL  |  DISEASES
6697  |  SPR  |  DISEASES
7276  |  TTR  |  DISEASES
1846  |  DUSP4  |  DISEASES
7291  |  TWIST1  |  DISEASES
35  |  ACADS  |  DISEASES
10047  |  CST8  |  DISEASES
5199  |  CFP  |  DISEASES
92797  |  HELB  |  DISEASES
7429  |  VIL1  |  DISEASES
7166  |  TPH1  |  DISEASES
3630  |  INS  |  DISEASES
10343  |  PKDREJ  |  DISEASES
7014  |  TERF2  |  DISEASES
6616  |  SNAP25  |  DISEASES
29969  |  MDFIC  |  DISEASES
2644  |  GCHFR  |  DISEASES
2184  |  FAH  |  DISEASES
23531  |  MMD  |  DISEASES
4591  |  TRIM37  |  DISEASES
23417  |  MLYCD  |  DISEASES
9135  |  RABEP1  |  DISEASES
25939  |  SAMHD1  |  DISEASES
7299  |  TYR  |  DISEASES
51430  |  SUCO  |  DISEASES
60482  |  SLC5A7  |  DISEASES
3004  |  GZMM  |  DISEASES
5443  |  POMC  |  DISEASES
11107  |  PRDM5  |  DISEASES
10661  |  KLF1  |  DISEASES
10058  |  ABCB6  |  DISEASES
38  |  ACAT1  |  DISEASES
6821  |  SUOX  |  DISEASES
6895  |  TARBP2  |  DISEASES
3073  |  HEXA  |  DISEASES
5373  |  PMM2  |  DISEASES
54957  |  TXNL4B  |  DISEASES
5226  |  PGD  |  DISEASES
52  |  ACP1  |  DISEASES
6988  |  TCTA  |  DISEASES
54539  |  NDUFB11  |  DISEASES
4915  |  NTRK2  |  DISEASES
932  |  MS4A3  |  DISEASES
5805  |  PTS  |  DISEASES
5860  |  QDPR  |  DISEASES
7074  |  TIAM1  |  DISEASES
3156  |  HMGCR  |  DISEASES
213  |  ALB  |  DISEASES
51151  |  SLC45A2  |  DISEASES
4982  |  TNFRSF11B  |  DISEASES
57094  |  CPA6  |  DISEASES
142940  |  TRUB1  |  DISEASES
5092  |  PCBD1  |  DISEASES
124935  |  SLC43A2  |  DISEASES
5617  |  PRL  |  DISEASES
51181  |  DCXR  |  DISEASES
1448  |  CSN3  |  DISEASES
25928  |  SOSTDC1  |  DISEASES
2548  |  GAA  |  DISEASES
686  |  BTD  |  DISEASES
51029  |  DESI2  |  DISEASES
2720  |  GLB1  |  DISEASES
3159  |  HMGA1  |  DISEASES
1808  |  DPYSL2  |  DISEASES
23209  |  MLC1  |  DISEASES
11322  |  TMC6  |  DISEASES
594  |  BCKDHB  |  DISEASES
2193  |  FARSA  |  DISEASES
6888  |  TALDO1  |  DISEASES
199699  |  DAND5  |  DISEASES
348932  |  SLC6A18  |  DISEASES
51733  |  UPB1  |  DISEASES
55748  |  CNDP2  |  DISEASES
121278  |  TPH2  |  DISEASES
170392  |  OIT3  |  DISEASES
10057  |  ABCC5  |  DISEASES
51738  |  GHRL  |  DISEASES
9376  |  SLC22A8  |  DISEASES
219541  |  MED19  |  DISEASES
10011  |  SRA1  |  DISEASES
5873  |  RAB27A  |  DISEASES
57142  |  RTN4  |  DISEASES
3363  |  HTR7  |  DISEASES
32  |  ACACB  |  DISEASES
392636  |  AGMO  |  DISEASES
124454  |  EARS2  |  DISEASES
875  |  CBS  |  DISEASES
31  |  ACACA  |  DISEASES
9188  |  DDX21  |  DISEASES
6050  |  RNH1  |  DISEASES
5265  |  SERPINA1  |  DISEASES
6898  |  TAT  |  DISEASES
54517  |  PUS7  |  DISEASES
5625  |  PRODH  |  DISEASES
83658  |  DYNLRB1  |  DISEASES
622  |  BDH1  |  DISEASES
157680  |  VPS13B  |  DISEASES
56980  |  PRDM10  |  DISEASES
1735  |  DIO3  |  DISEASES
773  |  CACNA1A  |  DISEASES
22871  |  NLGN1  |  DISEASES
280  |  AMY2B  |  DISEASES
1733  |  DIO1  |  DISEASES
1756  |  DMD  |  DISEASES
23038  |  WDTC1  |  DISEASES
4688  |  NCF2  |  DISEASES
2328  |  FMO3  |  DISEASES
632  |  BGLAP  |  DISEASES
959  |  CD40LG  |  DISEASES
5223  |  PGAM1  |  DISEASES
5236  |  PGM1  |  DISEASES
23203  |  PMPCA  |  DISEASES
1678  |  TIMM8A  |  DISEASES
2170  |  FABP3  |  DISEASES
6428  |  SRSF3  |  DISEASES
400746  |  NCMAP  |  DISEASES
3155  |  HMGCL  |  DISEASES
229  |  ALDOB  |  DISEASES
80324  |  PUS1  |  DISEASES
6520  |  SLC3A2  |  DISEASES
4129  |  MAOB  |  DISEASES
2592  |  GALT  |  DISEASES
444  |  ASPH  |  DISEASES
3030  |  HADHA  |  DISEASES
114899  |  C1QTNF3  |  DISEASES
4155  |  MBP  |  DISEASES
6430  |  SRSF5  |  DISEASES
2643  |  GCH1  |  DISEASES
23365  |  ARHGEF12  |  DISEASES
815  |  CAMK2A  |  DISEASES
4644  |  MYO5A  |  DISEASES
27124  |  INPP5J  |  DISEASES
3033  |  HADH  |  DISEASES
279  |  AMY2A  |  DISEASES
10165  |  SLC25A13  |  DISEASES
387  |  RHOA  |  DISEASES
84627  |  ZNF469  |  DISEASES
7148  |  TNXB  |  DISEASES
34  |  ACADM  |  DISEASES
441531  |  PGAM4  |  DISEASES
133396  |  IL31RA  |  DISEASES
5096  |  PCCB  |  DISEASES
8801  |  SUCLG2  |  DISEASES
4190  |  MDH1  |  DISEASES
5365  |  PLXNB3  |  DISEASES
9  |  NAT1  |  DISEASES
8972  |  MGAM  |  DISEASES
5053  |  PAH  |  DISEASES
2108  |  ETFA  |  DISEASES
23642  |  SNHG1  |  DISEASES
26812  |  SNORD37  |  DISEASES
Locus(Waiting for update.)
Disease ID 84
Disease phenylketonuria
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:3)
HP:0002564  |  Malformation of the heart and great vessels
HP:0003355  |  Aminoaciduria
HP:0010864  |  Intellectual disability, severe
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:17)
Disease ID 84
Disease phenylketonuria
Manually Symptom
UMLS  | Name(Total Manually Symptoms:36)
C2364114  |  tremor
C2188188  |  agoraphobia
C1963165  |  malabsorption
C1963139  |  hypopigmentation
C1963101  |  encephalopathy
C1027109  |  scleroderma
C0751434  |  phenylalanine hydroxylase deficiency
C0546817  |  hypervolaemia
C0455683  |  congenital heart disease
C0268559  |  hyperglycinemia
C0268477  |  indicanuria
C0262405  |  cerebral dysfunction
C0262405  |  brain dysfunction
C0242422  |  parkinsonism
C0238421  |  selenium deficiency
C0235946  |  cerebral atrophy
C0235031  |  neurological symptoms
C0220992  |  histidinaemia
C0042847  |  vitamin b12 deficiency
C0037822  |  speech disorders
C0037769  |  west syndrome
C0037285  |  skin manifestations
C0037284  |  skin lesions
C0036572  |  seizures
C0034013  |  true precocious puberty
C0030920  |  peptic ulcer disease
C0025517  |  metabolism disorders
C0025362  |  mental retardation
C0016751  |  hereditary fructose intolerance
C0015411  |  eye findings
C0014544  |  epilepsy
C0009951  |  convulsions
C0005940  |  bone disorders
C0004936  |  mental disorders
C0004096  |  bronchial asthma
C0002514  |  hyperaminoaciduria
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C0025362  |  mental retardation  |  3
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:166)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs118203921NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852881GA
rs118203923NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852926GA
rs140945592NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894918CA,T
rs142934616114611965053PAHumls:C0031485BeFreePopulation studies have suggested that the K274E variant occurs on approximately 4% of African-American PAH alleles, whereas the neonatal screening incidence of PKU among African Americans is only 1:100,000.0.3747285672001PAH12102852837TC
rs1799970NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840398AG
rs199475566NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912794A-
rs199475575NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855316GA
rs199475579NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852917CT,A
rs199475584NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843648TA
rs199475585NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102917073GA
rs199475598NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912794AC
rs199475634NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894904GT,C
rs199475641NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102839178-T
rs199475654NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852816GC,A
rs199475655NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102866597GC
rs199475657NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852935C-
rs199475659NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840414GT
rs199475680NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102877503GA
rs199475692NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852845TC,A
rs199475698NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102877456AT,G
rs202183605NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844432CG,T
rs281865428NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894737G-
rs281865429NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852820G-
rs281865430NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846932AG-
rs281865431NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894876-AGAAGG
rs281865432NA5053PAHumls:C0031485CLINVARNA0.374728567NANANANANANA
rs281865433NA5053PAHumls:C0031485CLINVARNA0.374728567NANANANANANA
rs281865434NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844397TG
rs281865435NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843682AG
rs281865436NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843649AG
rs281865437NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840475AG
rs281865438NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912795AG
rs281865439NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894737GA
rs281865440NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102866600GA
rs281865441NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855274CT
rs281865442NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855251CG
rs281865443NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855210GA
rs281865444NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855160CT
rs281865445NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852872AC
rs281865446NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851712TC
rs281865447NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843781TA
rs281865448NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102866665TG
rs281865449NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851685AG
rs281865450NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851684TG
rs281865451NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846954GC
rs281865452NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846959TC
rs281865453NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843674TC
rs281865454NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894891CA
rs281865455NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102866601GT
rs281865456NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846948T-
rs38662662178600625053PAHumls:C0031485BeFreeThe mutation S349P in exon 10 of the phenylalanine hydroxylase (PAH) gene was identified in one Norwegian and one Polish phenylketonuria (PKU) allele on a haplotype 1.7 background.0.3747285671995NANANANANA
rs38662662180952485053PAHumls:C0031485BeFreeA missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.0.3747285671993NANANANANA
rs386626622104718385053PAHumls:C0031485BeFreeIn this study we have performed in vivo analyses of lymphocyte PAH mRNA from PKU patients homozygous for the PKU missense mutations P281L and R408Q as well as the nonsense mutations G272X and Y356X.0.3747285671999NANANANANA
rs386626624104725295053PAHumls:C0031485BeFreeWe present a child in whom phenylketonuria was apparently caused by homozygosity for the mutation E390G in exon 11 of the phenylalanine hydroxylase (PAH) gene.0.3747285671999NANANANANA
rs386626638104718385053PAHumls:C0031485BeFreeIn this study we have performed in vivo analyses of lymphocyte PAH mRNA from PKU patients homozygous for the PKU missense mutations P281L and R408Q as well as the nonsense mutations G272X and Y356X.0.3747285671999NANANANANA
rs398123292NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102877548GA
rs398123294NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846909CA
rs5030654NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843756C-
rs5030841NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912816AG
rs5030843NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102866632CT,G
rs5030845NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855151AG
rs5030846NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852930GA
rs5030847NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852903GC,A
rs5030849NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852875CT,G
rs503084919155025053PAHumls:C0031485BeFreeMaternal phenylketonuria syndrome in cousins caused by mild, unrecognized phenylketonuria in their mothers homozygous for the phenylalanine hydroxylase Arg-261-Gln mutation.0.3747285671991PAH12102852875CT,G
rs5030849119999825053PAHumls:C0031485BeFreeWe report two new patients with tetrahydrobiopterin (BH4)-responsive phenylketonuria and compare their phenylalanine hydroxylase (PAH) genotypes (A395P/ IVS12+g>a and R261Q/165T, respectively) to those of previous cases from the literature.0.3747285672002PAH12102852875CT,G
rs5030850NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852876GC,A
rs5030851NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852815GA
rs5030852NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852814CT,A
rs5030853NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851701CA
rs5030854NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843769GC
rs5030855NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843790CT
rs5030856NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843676TC
rs5030857NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840507GA
rs503085878339275053PAHumls:C0031485BeFreeThe R408W mutation in the phenylalanine hydroxylase gene (PAH) of phenylketonuria patients occurs on haplotypes 2.3 and 1.8 in Europeans.0.3747285671994PAH12102840493GA
rs5030858125425805053PAHumls:C0031485BeFreeDifferent presentations of late-detected phenylketonuria in two brothers with the same R408W/R111X genotype in the PAH gene.0.3747285672003PAH12102840493GA
rs503085889461765053PAHumls:C0031485BeFreePhenylalanine hydroxylase gene mutation R408W is present on 84% of Estonian phenylketonuria chromosomes.0.3747285671996PAH12102840493GA
rs5030858126555485053PAHumls:C0031485BeFreeThe R408W phenylketonuria mutation in Europe has arisen by recurrent mutation in the human phenylalanine hydroxylase (PAH) locus and is associated with two major PAH haplotypes.0.3747285672003PAH12102840493GA
rs5030858190366225053PAHumls:C0031485BeFreeThe PAH mutant proteins (R158Q, I174T and R408W) that result in the classical phenylketonuria (PKU) phenotype expressing 0.2-1.8% of the wild type PAH activity when using phenylalanine as substrate were found to have <0.1% of the wild type PAH activity when SCMC was used as the substrate.0.3747285672009PAH12102840493GA
rs5030858113173605053PAHumls:C0031485BeFreeWe describe the application of the novel technique of Glycosylase Mediated Polymorphism Detection (GMPD) to the detection of two of the most common mutations of the PAH gene in the Irish population that cause phenylketonuria (PKU), R408W and I65T, which occur at relative frequencies of 41.0% and 10.4% respectively.0.3747285672001PAH12102840493GA
rs5030858NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840493GA
rs503085888083165053PAHumls:C0031485BeFreeWe have used the fluorescent multiplex ARMS method for the identification of common phenylketonuria mutations in Northern Ireland (R408W, 165T and F39L) together with the analysis of a polymorphic short tandem repeat site at the human phenylalanine hydroxylase locus.0.3747285671995PAH12102840493GA
rs5030859NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840492CT
rs5030860NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840474TC
rs5030861NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840399CT
rs62507321NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102877457CA
rs62507322NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840516CT
rs62507329102000575053PAHumls:C0031485BeFreeTwo novel mutations in exon 11 of the PAH gene (V1163del TG and P362T) associated with classic phenylketonuira and mild phenylketonuria. Mutations in brief no. 143. Online.0.3747285671998PAH12102843761GT,A
rs62507336NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855281CT,G
rs62507344NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843782GA
rs62507348NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855148GA
rs62508578NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844427TC
rs62508587NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855261AG-
rs62508588NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852929CT,A
rs6250864678600625053PAHumls:C0031485BeFreeThe mutation S349P in exon 10 of the phenylalanine hydroxylase (PAH) gene was identified in one Norwegian and one Polish phenylketonuria (PKU) allele on a haplotype 1.7 background.0.3747285671995PAH12102844356AG,C
rs6250864680952485053PAHumls:C0031485BeFreeA missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.0.3747285671993PAH12102844356AG,C
rs62508646NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844356AG,C
rs62508687NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852851A-
rs62508698NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852819CT,G
rs6250872190489355053PAHumls:C0031485BeFreeWe report the identification by denaturing gradient gel electrophoresis and sequence analysis of two new phenylalanine hydroxylase (PAH) gene mutations (IVS4nt-2 and N207S) in single chromosomes of two unrelated Italian phenylketonuric (PKU) patients.0.3747285671997PAH12102855222TC
rs62508727NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894801TGA-
rs62508752NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852861TG,C
rs62509013NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855194GC
rs62509015NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843645CT,G,A
rs62514891NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102917130TC,A
rs62514893NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102917128CT
rs62514895NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102917066CT,A
rs62514898NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912790CT
rs62514902NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894837CA
rs62514907NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102866664CT
rs62514927NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855231TC
rs62514934NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855180TC
rs62514950NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852848CT
rs62514952NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852843CA
rs62514953NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852839GA
rs62514955NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852813AT
rs62514956NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851686CT
rs62514959NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844424CT
rs62516092NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844359GC
rs62516095104718385053PAHumls:C0031485BeFreeIn this study we have performed in vivo analyses of lymphocyte PAH mRNA from PKU patients homozygous for the PKU missense mutations P281L and R408Q as well as the nonsense mutations G272X and Y356X.0.3747285671999PAH12102843777GT,C,A
rs62516095NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843777GT,C,A
rs62516101NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843683CT,G,A
rs62516103119999825053PAHumls:C0031485BeFreeWe report two new patients with tetrahydrobiopterin (BH4)-responsive phenylketonuria and compare their phenylalanine hydroxylase (PAH) genotypes (A395P/ IVS12+g>a and R261Q/165T, respectively) to those of previous cases from the literature.0.3747285672002PAH12102843662CG
rs62516109NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855204AG
rs62516141NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843688TC
rs62516142NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843665CG,A
rs62516146NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852810CT
rs62517166NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102877461CT,G
rs62517168NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851752TA
rs62642906NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102917083AG-
rs62642919NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851730TC,A
rs6264292688083165053PAHumls:C0031485BeFreeWe have used the fluorescent multiplex ARMS method for the identification of common phenylketonuria mutations in Northern Ireland (R408W, 165T and F39L) together with the analysis of a polymorphic short tandem repeat site at the human phenylalanine hydroxylase locus.0.3747285671995PAH12102912842GC
rs62642926NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912842GC
rs62642930NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852893AG
rs62642933NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851703AC
rs62642934NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846948TC
rs62642935NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846938GT,A
rs62642936NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102846932AG
rs62642937NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843706GA
rs62642939NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851709CT
rs62642941NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843716A-
rs62644473NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840495GA
rs62644503NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852902CT
rs74503222NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852912GA
rs74603784NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912823CT
rs74603784259205925053PAHumls:C0031485BeFreeA novel large deletion (exons 12, 13) and a missense mutation (p.G46R) in the PAH in a Japanese patient with phenylketonuria.0.3747285672014PAH12102912823CT
rs75193786113173605053PAHumls:C0031485BeFreeWe describe the application of the novel technique of Glycosylase Mediated Polymorphism Detection (GMPD) to the detection of two of the most common mutations of the PAH gene in the Irish population that cause phenylketonuria (PKU), R408W and I65T, which occur at relative frequencies of 41.0% and 10.4% respectively.0.3747285672001PAH12102894893AT,G,C
rs75193786NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894893AT,G,C
rs759154440NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855177TC-
rs762462102NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102912841AGA-
rs76296470NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894756GA
rs76394784NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894883TA
rs76687508NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852936GA
rs77958223NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102855309TC,A
rs786200861NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843751AGA-
rs786200862NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102843739AGCTCCAGGGGGAGA-
rs786204457NA5053PAHumls:C0031485CLINVARNA0.374728567NANANANANANA
rs78655458NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852828AC
rs794727086NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102839178CTTTA-
rs794727619NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102877546G-
rs796064501NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102844376GT
rs796064502NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102894845GT
rs796064503NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102852821GA
rs796064504NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102851704AG
rs7993149991240555053PAHumls:C0031485BeFreeA convenient molecular method for the detection of R413P (1238G-->C) mutation in exon 12 of the phenylalanine hydroxylase gene, one of the prevalent mutations among Japanese patients with classical phenylketonuria (PKU) is described.0.3747285671997PAH12102840477CG,T
rs79931499NA5053PAHumls:C0031485CLINVARNA0.374728567NAPAH12102840477CG,T
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0002059Cerebral atrophyMP:0003643spleen atrophy;HP:0001010Hypopigmentation of the skin
Mapped by homologous gene(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0001300ParkinsonismMP:0005402abnormal action potential;HP:0002099Asthma
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)